NCT02380222View on ClinicalTrials.gov

Patient-Reported Outcome Questionnaire for Systemic Mastocytosis

CompletedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Aggressive Systemic Mastocytosis (ASM)SM w Assoc Clonal Hema Non-mast Cell Lineage Disease (SM-AHNMD)Mast Cell Leukemia (MCL)Smoldering Systemic Mastocytosis (SSM)Indolent Systemic Mastocytosis (ISM) ISM Subgroup Fully Recruited
Interventions
OTHER

Interview

Single interview lasting approximately one hour

Trial Locations (1)

02210

Adelphi Values LLC, Boston

Sponsors
All Listed Sponsors
collaborator

Blueprint Medicines Corporation

INDUSTRY

lead

Adelphi Values LLC

INDUSTRY